ORGO
Price:
$2.44
Market Cap:
$313.97M
Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical and sports medicine applications. Within its advanced wound care portfolio, Organogenesis offers several distinct products. These include Affinity and Novachor, both amniotic membrane dressings designed to preserve vital cells, growth factors, and ECM proteins found in natural tissue. Apligraf is a bioengineered living cell therapy that releases a range of healing cytokines and growth factors, while Dermagraft is another bioengineered solution that generates human collagen, ECM, proteins, and cyto...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-01-05
Stock Exchange
NASDAQ
Ticker
ORGO
According to Organogenesis Holdings Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -20.33. This represents a change of -2521.76% compared to the average of 0.84 of the last 4 quarters.
The mean historical PE Ratio of Organogenesis Holdings Inc. over the last ten years is -95.31. The current -20.33 PE Ratio has changed 2.03% with respect to the historical average. Over the past ten years (40 quarters), ORGO's PE Ratio was at its highest in in the March 2022 quarter at 2.72K. The PE Ratio was at its lowest in in the June 2016 quarter at -24375.00.
Average
-95.31
Median
0.93
Minimum
-450.70
Maximum
108.49
Discovering the peaks and valleys of Organogenesis Holdings Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 383.96%
Maximum Annual PE Ratio = 108.49
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -450.70
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 32.38 | -107.18% |
| 2024 | -450.70 | -515.44% |
| 2023 | 108.49 | 383.96% |
| 2022 | 22.42 | 77.10% |
| 2021 | 12.66 | -73.10% |
| 2020 | 47.06 | -530.51% |
| 2019 | -10.93 | 1.24% |
| 2018 | -10.80 | -96.43% |
| 2017 | -302.44 | -24.62% |
| 2016 | -401.23 | -Infinity% |
The current PE Ratio of Organogenesis Holdings Inc. (ORGO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-103.28
5-year avg
-54.95
10-year avg
-95.31
Organogenesis Holdings Inc.’s PE Ratio is greater than SNDL Inc. (-37.31), greater than Monopar Therapeutics Inc. (-32.59), greater than Emergent BioSolutions Inc. (-47.06), greater than Esperion Therapeutics, Inc. (-130.17), less than Evolus, Inc. (-9.93), less than SIGA Technologies, Inc. (15.08), less than AngioDynamics, Inc. (-16.20), less than Bicycle Therapeutics plc (-1.27), less than Varex Imaging Corporation (-5.28), less than Compass Therapeutics, Inc. (-5.52),
| Company | PE Ratio | Market cap |
|---|---|---|
| -37.31 | $369.63M | |
| -32.59 | $451.99M | |
| -47.06 | $412.77M | |
| -130.17 | $654.91M | |
| -9.93 | $436.62M | |
| 15.08 | $309.85M | |
| -16.20 | $502.02M | |
| -1.27 | $277.58M | |
| -5.28 | $443.31M | |
| -5.52 | $279.34M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organogenesis Holdings Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Organogenesis Holdings Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Organogenesis Holdings Inc.'s PE Ratio?
How is the PE Ratio calculated for Organogenesis Holdings Inc. (ORGO)?
What is the highest PE Ratio for Organogenesis Holdings Inc. (ORGO)?
What is the 3-year average PE Ratio for Organogenesis Holdings Inc. (ORGO)?
What is the 5-year average PE Ratio for Organogenesis Holdings Inc. (ORGO)?
How does the current PE Ratio for Organogenesis Holdings Inc. (ORGO) compare to its historical average?